James T Lafrance, a director of Vermillion, recently acquired 9,205 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on March 19, 2021. Lafrance now owns 422,439 shares of the company. Lafrance operates out of Austin, TX. Some additional info was provided as follows:
The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021.
Total reflects the adjustment of 21,246 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020.
The employee stock option will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Vermillion makes a similar move, sign up!
Other recent filings from the company include the following:
Vermillion's President and CEO was just granted 5,000 options - Sept. 1, 2022
Vermillion's General Counsel & Secretary just picked up 26,667 shares - Aug. 30, 2022
Vermillion director just picked up 13,332 shares - Aug. 29, 2022
Vermillion's President & CEO just picked up 66,667 shares - Aug. 29, 2022
Jack W. Schuler Living Trust just provided an update on activist position in Vermillion - Aug. 29, 2022